Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers

Houtan Noushmehr(Henry Ford Health System), A. J. Castro(Henry Ford Health System), Dhananjay Chitale(Henry Ford Hospital), Michael Wells(Henry Ford Health System), Abir Mukherjee(University of Chicago), Adam Robin(Ford Motor Company (United States)), TM Malta(Henry Ford Health System), T Sabedot(Henry Ford Health System), Jason R. Rock(Gene Therapy Laboratory), Kimberly M. Nelson(Henry Ford Health System), Tom Mikkelsen(Henry Ford Health System), Ana C. deCarvalho(Henry Ford Hospital), Karam Asmaro(Harvard University), L. Poisson(Henry Ford Health System), I Lee(Henry Ford Health System), Maritza Mosella(Henry Ford Health System), Mark L. Rosenblum(Henry Ford Health System), Steven N. Kalkanis(Henry Ford Health System), J Snyder(Henry Ford Health System), Tobias Walbert(Henry Ford Health System)
bioRxiv (Cold Spring Harbor Laboratory)
April 8, 2019
Cited by 11


Related Papers